SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-22-000290
Filing Date
2022-01-31
Accepted
2022-01-31 10:58:24
Documents
1
Group Members
HAREL INSURANCE CO LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2227147.htm SC 13G/A 87583
  Complete submission text file 0001178913-22-000290.txt   89185
Mailing Address HAREL HOUSE, 3 ABBA HILLEL ST. RAMAT GAN L3 52118
Business Address HAREL HOUSE, 3 ABBA HILLEL ST. RAMAT GAN L3 52118 972-3-7547090
Harel Insurance Investments & Financial Services Ltd. (Filed by) CIK: 0001429390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Subject) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91506 | Film No.: 22571879
SIC: 2836 Biological Products, (No Diagnostic Substances)